5-ht6 receptors

Current Drug Targets: CNS and Neurological Disorders

Volumn 3, Issue 1, 2004, Pages 59-79

  Woolley, Marie L ^a,b   Marsden, Charles A ^a   Fone, Kevin C F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIDINYL]BENZENESULFONAMIDE; 4 AMINO N [2,6 BIS(METHYLAMINO) 4 PYRIMIDINYL]BENZENESULFONAMIDE; 4 AMINOBUTYRIC ACID; 5 CARBAMOYLTRYPTAMINE; 5 CHLORO N (4 METHOXY 3 PIPERAZIN 1 YL PHENYL) 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; 5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; AMITRIPTYLINE; ATROPINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; COMPLEMENTARY DNA; ERGOTAMINE; GLUTAMIC ACID; KETANSERIN; LISURIDE; LOXAPINE; MESULERGINE; METERGOLINE; METHYSERGIDE; METITEPINE; MIANSERIN; PROTEIN KINASE C; RITANSERIN; SCOPOLAMINE; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SULFONAMIDE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; SEROTONIN AGONIST;

AFFECT; ALZHEIMER DISEASE; ANXIETY; BINDING AFFINITY; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; COGNITION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EPILEPSY; FEEDING; GENETICS; HUMAN; LIMBIC CORTEX; MOLECULAR CLONING; MOOD DISORDER; NOMENCLATURE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSYCHOSIS; REGULATORY MECHANISM; REVIEW; SCHIZOPHRENIA; SEIZURE; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; ANIMAL; BRAIN; CLASSIFICATION; DRUG EFFECT; DRUG SCREENING; FEEDING BEHAVIOR; GENETIC POLYMORPHISM; LEARNING; MENTAL DISEASE; METABOLISM; METHODOLOGY; MOUSE; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CLONING, MOLECULAR; DRUG EVALUATION; FEEDING BEHAVIOR; HUMANS; LEARNING; MENTAL DISORDERS; MICE; NEURONS; POLYMORPHISM, GENETIC; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 3042765589     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007043482561     Document Type: Review

References (136)

1. Hoyer, D., Hannon, J.P., Martin, G.R. Biochem. Behav., 2002, 71, 533-554.
2. Monsma, F.J. Jr., Shen, Y., Ward, R.P., Hamblin, M.W., Sibley, D.R. Mol. Pharmacol., 1993, 43, 320-327.
3. Ruat, M., Traiffort, E., Arrang, J.M., Tardivel-Lacombe, J., Diaz, J., Leurs, R., Schwartz, J.C. Biochem. Biophys. Res. Commun., 1993, 193, 268-276.
4. Kohen, R., Metclaf, M.A., Khan, N., Druck, T., Huebner, K., Lachowicz, J.E., Meltzer, H.Y., Sibley, D.R., Roth, B.L.; Hamblin, M.W. J. Neurochem., 1996, 66, 47-56.
5. Kohen, R., Fashingbauer, L.A., Heidmann, D.E.A., Guthrie, C.R., Hamblin, M.W. Mol. Brain Res., 2001, 90, 110-117.
6. Schmuck, K., Ullmer, C., Engels, P., Lubbert, H. FEBS Lett., 1994, 342, 85-90.
7. Kennett, G.A. Current Opinion Investigation Drugs, 1993, 2, 317-362.
8. Bourson, A., Borroni, E., Austin, R. H., Monsma, F. J. Jr., Sleight, A. J., J. Pharmacol. Exp. Ther, 1995, 274, 173-180.
9. Bentley, J.C., Sleight, A.J., Marsden, C.A., Fone, K.C.F. J. Psychopharmacol., 1997, 11, A64.
10. Yoshioka, M., Matsumoto, M., Togashi, H., Mori, K., Saito, H. Life Sci., 1998, 62, 1473-1477.
11. Unsworth, C.D., Molinoff, P.B., J. Pharmacol. Exp. Ther., 1994, 269, 246-255.
12. Otano, A. Frechilla, D. Cobreros, A. Cruz-Orive, L.M. Insausti, A. Insausti, R. Hamon, M. And Rio, J.D. Neurosci., 1999, 92, 1001-1009.
13. Sleight, A. J., Boess, F. G., Bus, M., Levet-Trafit, B., Riemer, C., Bourson, A. Brit. J. Pharmacol., 1998, 124, 556-562.
14. Bromidge, S.M., Brown, A.M., Clarke, S.E., Dodgson, K., Gager, T., Grassam, H.L., Jeffrey, P.M., Joiner, G.F., King, F.D., Middlemiss, D.N., Moss, S.F., Newman, H., Riley, G., Routledge, C., Wyman, P. J. Med. Chem., 1999, 42, 202-205.
15. Bromidge, S.M., Clarke, S.E., Gager, T., Griffith, K., Jeffrey, P., Jennings, A.J., Joiner, G., King, F.D., Lovell, P.J., Moss, S.F., Newman, H., Riley, G., Rogers, D., Routledge, C., Serafinowska, H., Smith, D.R. Bioorg. Med. Chem. Lett., 2001a, 11, 55-58.
16. Bromidge, S.M. et al. Med. Chem. Lett., 2001b, 11, 2843-2846.
17. Issac, M., Slassi, A., Xin, T., Maclean, N., Wilson, J., Mccallum, K., Wang, H., Demchyshyn, L. Bioorg. Med. Chem. Lett., 2000, 10, 1719-1721.
18. Tsai, Y., Dukat, M., Slassi, A., Maclean, N., Demschyshyn, L., Savage, J.E., Roth, B.L., Hufesein, S., Lee, M., Glennon, R.A. Bioorg. Med. Chem. Lett., 2000, 10, 2295-2299.
19. Lee, M., Ragisetty, J.B., Dukat, M., Slassi, A., Maclean, N., Lee, D.K.H., Glennon, R.A. Med. Chem. Res., 2000, 10, 230-242.
20. Slassi, A., Edwards, L., O'brien, A., Xin, T., Tehim, A. U.S. Patent, 2000, 6, 133, 287.
21. Russell, M.G.N., Baker, R.J., Barden, L., Beer, M.S., Bristow, L., Broughton, H.B., Knowles, M., Mcallister, G., Patel, S., Castro, J.L. J. Med. Chem, 2001, 44, 3881-3895.
22. Bös, M., Sleight, A.J., Godel, T., Martin, J.R., Riemer, C., Stadler, H. Eur. J. Med. Chem., 2001, 36, 165-178.
23. Reimer, C., Borroni, E., Levet-Trafit, B., Martin, J.R., Poli, S., Porter, R.H.P., Bos, M. J. Med Chem., 2003, 46, 1273-1276.
24. Roth, B.L., Craigo, S.C., Choudhary, M.S., Ulver, A., Monsma, F.J. Jr., Shen, Y., Meltzer, H.Y., Sibley, D.R., J. Pharmacol. Exp. Ther., 1994, 263, 1403-1410.
25. Tsai, S-J., Shiu, H-J., Wang, Y-C., Hong, C-J., Neurosci. Lett., 1999b, 271, 135-137.
26. Yu, W-Y. Y., Tsai, S-J., Lin, C-H., Hsu, C-P., Yang, K-H., Hong, C-J. Neuroreport, 1999, 10, 1231-1233.
27. Pouzet, B., Didriksen, M., Arnt, J. Behavioural Pharmacology, 2001, 12, S80.
28. Yau, J.L.W., Noble, J., Widdowson, J, Seckl, J.R. Mol. Brain Res., 1997, 45, 182-186.
29. Vogt, I.R., Shimron-Abarbanell, D., Neidt, H., Erdmann, J., Cichon, S., Schulze, T.G., Muller, D.J., Maier, W., Albus, M., Borrmann-Hassenbach, M., Knapp, M., Rietschel, M., Propping, P., Nothen, M.M. American Journal of Medical Genetics, 2000, 96, 217-221.
30. Routledge, C., Bromidge, S. M., Moss S. F., Price, G. W., Hirst, W., Newman, H., Riley, G., Gager, T., Stean, T., Upton, N., Clarke, S. E., Brown, A. M., Middlemiss, D. N. Brit. J. Pharmacol, 2000, 130, 1606-1612.
31. Bentley, J.C., Marsden, C.A., Sleight, A.J., Fone, K.C.F. Brit. J. Pharmacol., 1999b, 126, 66P.
32. Woolley, M.L., Bentley, J.C., Sleight, A.J., Marsden, C.A., Fone, K.C.F., Neuropharmacol., 2001, 41, 210-219.
33. Tsai, S-J., Liu, H-C., Liu, T-Y., Wang, Y-C., Hong, C-J. Neurosci Letts., 1999a, 276, 138-139.
34. Rogers, D.C., Hagan, J.J., Psychopharmacol., 2001, 158, 114-119.
35. Max, S.I., Monsma, F.J. Jr., Sibley, D.R. J. Serotonin Res., 1995, 2, 101-116.
36. Branchek, T.A., Blackburn, T.P. Annual Rev. Pharmacol. Toxicol., 2000, 140, 319-334.
37. Pauwels, P.J., Wurch, T. Mol. Neurobiol., 1998, 17, 109-135.
38. Lefkowitz, R.J., Caron, M.G. J. Biol. Chem, 1988, 263, 4993-4996.
39. Olsen, M.A., Nawoschik, S.P., Schurman, B.R., Scmitt, H.L., Burno, M., Smith, D.L. Schecter, L.E. Mol. Brain Res., 1999, 64, 255-263.
40. Boess, F.G., Monsma, F.J. Jr., Meyer, V., Zwingelstein, C., Sleight, A.J. Mol. Pharmacol., 1997b, 52, 515-523.
41. Boess, F.G., Monsma, F.J. Jr., Sleight, A.J. J. Neurochem., 1998a, 71, 2169-2177.
42. Hirst, W.D., Abrahamsen, B., Biancy, F.E., Calvet, A.R., Aloj, L., Price, G.W., Medhurst, A.D. Mol. Pharmacol., 2003, 64, 1295-1308.
43. Stefulj, J., Jernej, B., Cicin-Sain, L., Rinner, I., Schauenstein, K. Brain Behav. Immun., 2000, 14, 219-224.
44. Ward, R.P., Hamblin, M.W., Lachowicz, J.E., Hoffman, B.J., Dibley, D.R. & Dorsat, D.M. Neuroscience, 1995, 64, 1105-1111.
45. Gerard, C., Mestikawy, Lebrand, C., Adreien, J., Ruat, M., Traiffort, E., Hamon, M. Martres, M.-P. Synapse, 1996, 23, 164-173.
46. Pierce, P.A., Xie, G.X., Levine, J.D., Peroutka, S.J. Neuroscience, 1996, 70, 553-559.
47. Kinsey, A.M., Wainwright, A., Heavens, R., Sirinathsinghji, D.J.S., Oliver, K.R. Mol. Brain Res., 2001, 88, 194-198.
48. Roberts, J.C., Hirst, W.D., Reavil, C., Patel, S., Routledge, C., Leslie, R.A. Brit. J. Pharmacol., 1999, 128, P110.
49. Roberts, J.C., Reavil, C., East, S.Z., Harrison. P.J., Patel, S., Routledge, C., Leslie, R.A. Brain Res., 2002, 934, 49-57.
50. Woolley, M.L., Marsden, C.A., Sleight, A.J., Fone, K.C.F. Brain Research Bulletin conference, Serotonin: From the Molecule to the Clinic, 2000a, p95.
51. Fone, K.C.F., Marsden, C.A., Bentley, J.C., Woolley, M.L. Abstract from 5th IUPHAR Meeting on Serotonin, 2002, p77.
52. Branchek, T.A. Seminars in the Neurosciences, 1995, 7, 375-382.
53. Sleight, A.J., Boess, F.G., Bourson, A., David, R.S. & Monsam, F.J. Jr. Drug News and Perspectives, 1997, 10, 214-224.
54. Boess, F.G., Riemer, C., Bos, M., Bentley, J., Bourson, A., Sleight, A.J. Mol. Pharmacol., 1998b, 54, 577-583.
55. Ward, R.P. Dorsa, D.M. J. Comp. Neurol., 1996, 370, 405-414.
56. Boess, F.G., Monsma, F.J. Jr., Carolo, V., Meyer, V., Rudler, A., Zwinglestein, C. & Sleight, A.J. Neuropharmacology, 1997a, 36, 713-720.
57. Sebben, M., Ansanay, H., Bockaert, J. & Dumuis, A. Neuroreport, 1994, 5, 2553-2557.
58. Renault, J., Fabis, F., Dauphin, F., Lebranchu, M., Le Roch, M., Butt, S., Uriac, P., Rault, S. J. Pharm. Pharmacol, 2001, 53, 969-972.
59. Stean, T.O., Hirst, W.D., Thomas, D.R., Price, G.W., Rogers, D., Riley, G., Bromidge, S.M., Serafinowska, H.T., Smith, D.R., Bartlett, S., Deeks, N., Duxon, M., Upton, N. Pharmacol, Biochem. Behav., 2002, 71, 645-654.
60. Minton, J.A.L., Hirst, W.D., Bromidge, C., Routledge, C., Middlemiss, D.N., Price, G.W.. Brit. J. Pharmacol., 1999, 128, P111.
61. Hirst, W.D., Minton, J.A.L., Bromidge, S.M., Routledge, C., Middlemiss, D.N., Price, G.W. Brit. J. Pharmacol., 1999, 121, 23P.
62. Hirst, W.D., Babbs, A.J., Minton, J.A.L., Rogers, D.C., Moss, S.F., Bromidge, S.M., Stean, T., Price, G.W. Brit. J. Pharmacol., 2000a, 131, 190P.
63. Hirst, W.D., Minton, J.A.L., Bromidge, S.M., Moss, S.F., Latter, A.J., Riley, G., Routledge, C., Middlemiss, D.N., Price, G.W. Brit. J. Pharmacol., 2000b, 130, 1597-1605.
64. Glennon, R.A., Lee, M., Rangisetty, J.B., Dukat, M., Roth, B.L., Savage, J.E., Mcbride, A., Rauser, L., Hufeisen, S., Lee, D.K.H. J. Med. Chem., 2000, 43, 1011-1018.
65. Russell, M.G.N., Dias, R.,. Current Topics in Medicinal Chemstry, 2002, 2, 643-654.
66. Wesolowska, A. Pol. J. Pharmacol., 2002, 54, 327-341.
67. Wolff, M.C., Overshiner, C., Leander, J.D. Abstr. Soc. Neurosci., 2002, 586.1.
68. Schoeffter, P., And Waeber, C. Naunyn Schmiedebergs Arch. Pharmacol., 1994, 350, 356-360.
69. Liu, H-C., Hong, C-J., Liu, C-Y., Lin, K-N., Tsai, S-J., Liu, S-Y., Chi, C-W., Wang, P.-N. Psychiatry Clin Neurosci., 2001, 55, 427-429.
70. Alvarez-Alvarez, M., Galdos, L., Fernandez-Martinez, M., Gomez-Busto, F., Garcia-Centeno, V., Arias-Arias, C., Sanchez-Salazar, C., Rodriguez-Martinez, A.B., Zarranz, J.J., De Pancorbo, M.M. Neurosci. Letts, 2003, 339, 85-87.
71. East, S.Z., Burnet, P.W.J.,Leslie, R.A., Roberts, J.C., Harrison, P.J. Synapse, 2002, 45, 191-199.
72. Baader, M., Retz, W., Pesold, B., Hu, M., Rosler, M., Henn, F.A., Thornew, J. Eur. J. Neurosci., 2000, 12, 267P.
73. Shinkai, T., Ohmori, O., Kojima, H., Terao, T., Suzuki, T., Abe, K. Am. J. Med. Gen., 1999, 88, 120-122.
74. Chui, H.J., Wang, Y.C., Liou, J.H., Chao, C.H., Lee, H., Tsai, K.Y., Liu, W.C. Neuropsychobiology, 2001, 43, 113-116.
75. Huezo-Diaz, P., Dempster, D.B., Gutierrez, B., Munro, J., Osborne, Arranz, M.J., Kerwin, R. Am. J. Med. Gen., 2000, 96, P265.
76. Staddon, S.L., Mata, I., Osborne, S., Munro, J., Huezo-Diaz, P., Aranz, M.J., Kerwin, R.W. Am. J. Med. Gen., 2001, 105, P76.
77. Masellis, M., Basile, V.S., Meltzer, H.Y., Lieberman, J.A., Sevy, S., Goldman, D.A., Hamblin, M.W., Macciardi, F.M., Kennedy, J.L. Schizophrenia Res., 2001, 47, 49-58.
78. Hong, C-J., Tsai, S-J., Cheng, C-Y., Liao, W-Y., Lai, H-C. Am. J. Med. Gen., 1999, 88, 601-602.
79. Wu, W.H., Huo, S.J., Cheng, C.Y., Hong, C.J., Tsai, S.J. Neuropsychobiology, 2001, 44, 172-175.
80. Glatt, C.E., Snowman, A.M., Sibley, D.R., Snyder, S.H. Mol. Med., 1995, 1, 398-406.
81. Zhukovskaya, N.L. Neumaier, J.F. Neurosci. Lett, 2000, 288, 236-240.
82. Bourson, A., Boess, F. G., Bos, M., Sleight, A. J. Brit. J. Pharmacol., 1998, 125, 1562-1566.
83. Ouagazzal, A.-M., Grottick, A.J., Moreau, J.-L., Higgins, G.A. Neuropsychopharmacol, 2001, 25, 565-575.
84. Gérard, C., Martres, M.P., Lefevre, K., Miquel, M-C., Verge, D., Lanfumey, L., Doucet, E., Hamon, M. Mestikaway, Brain Research, 1997, 746, 207-219.
85. Ohmori, O., Shinkai, T., Hori, H., Nakamura, J. Neurosci. Lett, 2001, 310, 17-20.
86. Huezo-Diaz, P., Dempster, D.B., Gutierrez, B., Munto, J., Osbourne, S., Arranz, M.J., Kerwin, R.W. Schizophrenia Res., 2001, 49, Suppl., 71.
87. Gobbi, M., Moia, M., Pirona, L., Morazzoni, P., Mann-Lni, T. Pharmacopsychiatry, 2001, 34, S45-S45.
88. Tecott, L.H., 2000, Brain Research Bulletin-conference: Serotonin: from the molecule to the clinic.
89. Bonasera, S.J., Tecott, L.H. Pharmacol. Ther., 2000, 88, 133-142.
90. Ase, A.R., Reader, T.A., Hen, R., Riad, M., Descarries, L. J. Neurochem., 2000, 75, 2415-2426.
91. Lucas, J.J., Hiroi, N., Yamamoto, A., Buhot, M.C., Nestler, E., Hen, R. Abstr. Soc. Neurosci., 1997, 23, 971.
92. Gossen, M., Bujard, H. Proc. Natl. Acad. Sci. U.S.A., 1992, 89, 5547-5551.
93. Dawson, L.A., Nguyen, H.Q., Li, P. Neuropsychopharmacol., 2001, 25, 662-668.
94. Reavill, C., Rogers, D.C. Current Opinion in Investigational Drugs, 2001, 2, 104-109.
95. Rogers, D.C., Robinson, T.L., Quilter, C.A., Hunter, A.J., Routledge, C., Hagan, J.J. Brit. J. Pharmacol., 1999, 121, 22P.
96. Ennaceur, A., Aggleton, J.P. Exp. Brain Res., 1994, 100, 85-92.
97. Clark, R.E., Zola, S.M., Squire, L.R. J. Neurosci., 2000, 20, 8853-8860.
98. Mumby, D.G., Gaskin, S., Glenn, M.J, Schramek, T.E., Lehmann, H. Learn Mem., 2002, 9, 49-57.
99. Woolley, M.L., Marsden, C.A., Sleight, A.J., Fone, K.C.F. Brit. J. Pharmacol., 2000b, 129: 64P.
100. Woolley, M.L. Marsden, C.A., Sleight, A.J., Fone, K.C.F. Psychopharmacology, 2003, 170, 358-367.
101. Sleight, A.J., Consolo, S., Martin, J.R., Boes, M., Boess, F.G., Bentley, J.C., Bourson, A. Behav Pharmacol, 1999, 10, S86.
102. Lanthorn, T.H., Isaacson, R.L. Psychopharmacology, 1979, 65, 317-318.
103. Izquierdo, I. Drug Dev. Res., 1993, 30, 1-17.
104. Ramirez, M.J., Cenarruzabeitia, E., Lasheras, B., Delrio, J. Brain Res., 1996, 712, 274-280.
105. Diez-Ariza, M., Ramirez, M.J., Lasheras, B., Del Rio, J. Brain Res., 1998, 801, 228-232.
106. Milner, T.A., Veznedaroglu, E. J. Neurosci. Res., 1993, 36, 260-271.
107. Leranth, C., Vertes, R.P. J. Comp. Neurol., 1999, 410, 586-598.
108. Freund, T.F., Gulyas, A.I., Acsady, L., Gorcs, T., Toth, K. Proc. Natl. Acad. Sci. U.S.A., 1990, 87, 8501-8505.
109. Freund, T.F. Epilepsy Res. Suppl., 1992, 7, 79-91.
110. Kenakin, T.P., Bond, R.A., Bonner, T.I. Pharmacol. Rev., 1992, 44, 351-362.
111. Bradley, P.B., Engel, G., Feniuk, W., Fozard, J.R., Humphrey, P.P.A., Middlemiss, D.N., Myecharane, E.J., Richardson, B.P., Saxena, P.R. Neuropharmacology, 1986, 25, 563-576.
112. Martin, G.R. Humphrey, P.P.A. Neuropharmacology, 1994, 33, 261-273.
113. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martine, G.R., Mylecharane, E.J., Saxena, P.R., Humphrey, P.P.A. Pharmacol. Rev., 1994, 46, 157-203.
114. Orlacchio, A., Kawarai, T., Paciotti, E., Stefani, A., Orlacchio, A., Sorbi, S., St George-Hyslop, P.H., Bernardi, G. Neurosci. Lett., 2002, 325, 13-16.
115. Zhang, M., Yuan, G., Yao, J., Qian, Y., Zhang, X., Huang, Y., Tang, R., Ji, Q., Jiang, S. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2003, 20, 69-71.
116. Annesi, G., Ciro Candiano, I.C., Serra, P., Pasqua, A.A., Annesi, F., Tomanio, C., Spadafora, P., Carrideo, S., Civitelli, D., De Marco, E.V., Mangone, L., Nicoletti, G., Messina, D., Quattrone, A. Am. J. Hum. Genet., 2001, 69, 1848.
117. Meneses, A. Behav. Brain Res., 2001, 118, 107-110.
118. King, M.V, Woolley, M.W., Sleight, A.J., Marsden, C.A., Fone, K.C.F. J. Psychopharmacol., 2003, 17, A65.
119. Brailov, I., Bancila, M., Brisorgueil, M-J., Miquel, M-C., Hamon, M., Verge, D., Brain Res, 2000, 872, 271-275.
120. Simmen, U., Burkard, W., Berger, K., Schaffner, W., Lundstrom, K. J. Recept. Signal Transduct. Res., 1999, 19, 59-74.
121. Bartus, R. T., Dean, R. L., Beer, B. & Lippa, A. S. Science, 1982, 217, 408-417.
122. Stean, T., Routledge, R., Upton, N. Brit. J. Pharmacol., 1999, 130, P131.
123. Conner, D.A. Mol. Pharmacol., 1990, 37, 742-751.
124. Tecott, L.H., Chn, H.M., Brennan, T.J. fourth IUPHAR, Sattelite Meeting on Serotoni, 1998, SI.2.
125. Hamon, M., Doucet, E., Lefevre, K., Miquel, M.-C., Lanfumey, L., Insausti, R., frechilla, D., Del Rio, J., Verge, D. Neuropsychopharmacology, 2001, 21, 68-76.
126. Fillion, G., rousselle, J.C., Beandoin, D., Pradelles, P., goiny, M., Dray, F., Jacob, J. Life Sci., 1979, 24, 1813-1822.
127. Bös, M., Sleight, A.J., Godel, T., Martin, J.R., reimer, C., Stadler, H. Eur. J. med. Chem., 2001, 36, 165-178.
128. Glennon, R.A., Bondreu, M., Roth, B. Med. Chem. Res., 1999, 9, 108-117.
129. Thome, J., Retz, W., Baader, M., Pesold, B., Hu, M., Cowen, M., Durany, N., Adler, G., Henn, F.A., Roler, M. J. Neurol. Transm., 2001, 108, 1175-1180.
130. Fredrick, J.A., Meador-Wrodruff, J.H. Schizophr. Res., 1999, 38, 7-12.
131. Ireland, M.D., Cilia, J., Jones, D.N.R., Routledge, C., Leslie, R.A. Brit. J. Pharmacol., 1999, 1999, 128, 113P.
132. Shirazi-Southall, S., Rodriguez, D.E., Nomikes, G.G. Neuropsychopharmacology, 2002, 26, 583-594.
133. Dawson, L.A., Nguyen, H.Q., Li, P. Brit. J. Pharmacol., 2003, 130, 23-26.
134. Bliss, T.V.P., Collingridge, G.L. Nature, 1993, 361, 31-39.
135. Healy, D.J., Meador-Woodruff, J.H. Neuropsychopharmacology, 1999, 2, 341-351.
136. Bentley, J.C., Sleight, A.J., Marsder, C.A., Fone, K.P.F. Brit. J. Pharmacol., 1999b, 126, 66P.